APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fukangning Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Fukangning Tablets Market Outlook and Growth Opportunities 2026

26 December 2025212 pages

Choose your research edition.

Industry ResearchFukangning Tablets Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Fukangning Tablets Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Fukangning Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fukangning Tablets Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Fukangning Tablets Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Fukangning Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Fukangning Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fukangning Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fukangning Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Fukangning Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Fukangning Tablets market include Yili Pharmaceutical (Nanning) Co., Ltd., Yantai Bohai Pharmaceutical Group Co., Ltd., Tonghua Baixin Pharmaceutical Co., Ltd., Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd., Shaanxi Panlong Pharmaceutical Group Co., Ltd., Shaanxi Kanghui Pharmaceutical Co., Ltd., Sanmenxia Guangyu Biopharmaceutical Co., Ltd., Liaoning Dongfangren Pharmaceutical Co., Ltd. and Lanzhou Weici Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fukangning Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fukangning Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fukangning Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fukangning Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Fukangning Tablets Segment by Company

Yili Pharmaceutical (Nanning) Co., Ltd.

Yantai Bohai Pharmaceutical Group Co., Ltd.

Tonghua Baixin Pharmaceutical Co., Ltd.

Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd.

Shaanxi Panlong Pharmaceutical Group Co., Ltd.

Shaanxi Kanghui Pharmaceutical Co., Ltd.

Sanmenxia Guangyu Biopharmaceutical Co., Ltd.

Liaoning Dongfangren Pharmaceutical Co., Ltd.

Lanzhou Weici Pharmaceutical Co., Ltd.

Lanzhou Foci Pharmaceutical Co., Ltd.

Jinhua Kangshou Pharmaceutical Co., Ltd.

Jiangsu Yihai Pharmaceutical Co., Ltd.

Jilin Jurentang Pharmaceutical Co., Ltd.

Huaihua Zhenghao Pharmaceutical Co., Ltd.

Henan Zhongjing Pharmaceutical Co., Ltd.

Guangzhou Xiangxue Pharmaceutical Co., Ltd.

Guangxi Weiwe Pharmaceutical Co., Ltd.

Guangxi Shuangyi Pharmaceutical Co., Ltd.

Guangxi Jinsuozi Pharmaceutical Co., Ltd.

Guangxi Fanglue Pharmaceutical Group Co., Ltd.

Guangxi Bangqi Pharmaceutical Group Co., Ltd.

Fukangning Tablets Segment by Type

Film-coated Tablets

Sugar-coated Tablets

Fukangning Tablets Segment by Application

Hospital

Clinic

Other

Fukangning Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Fukangning Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Fukangning Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fukangning Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Fukangning Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fukangning Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fukangning Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fukangning Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fukangning Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fukangning Tablets industry.

Chapter 3: Detailed analysis of Fukangning Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Fukangning Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Fukangning Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fukangning Tablets Industry Trends Table 2. Fukangning Tablets Industry Drivers Table 3. Fukangning Tablets Industry Opportunities and Challenges Table 4. Fukangning Tablets Industry Restraints Table 5. Global Fukangning Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fukangning Tablets Revenue Share by Company (2021-2026) Table 7. Global Fukangning Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Fukangning Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Fukangning Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Fukangning Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Fukangning Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Fukangning Tablets Company, Product Type & Application Table 13. Global Fukangning Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Fukangning Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Film-coated Tablets Table 18. Significant Companies of Sugar-coated Tablets Table 19. Global Fukangning Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Fukangning Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Fukangning Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Fukangning Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Fukangning Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Fukangning Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Fukangning Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Fukangning Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Fukangning Tablets Sales Value Share by Type (2021-2026) Table 28. Global Fukangning Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Fukangning Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Fukangning Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Fukangning Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Fukangning Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Fukangning Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Fukangning Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Fukangning Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Fukangning Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Fukangning Tablets Sales Value Share by Application (2021-2026) Table 41. Global Fukangning Tablets Sales Value Share by Application (2027-2032) Table 42. Global Fukangning Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Fukangning Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Fukangning Tablets Sales Market Share by Region (2021-2026) Table 45. Global Fukangning Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Fukangning Tablets Sales Market Share by Region (2027-2032) Table 47. Global Fukangning Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Fukangning Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Fukangning Tablets Sales Value Share by Region (2021-2026) Table 50. Global Fukangning Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Fukangning Tablets Sales Value Share by Region (2027-2032) Table 52. Global Fukangning Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Fukangning Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Fukangning Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Fukangning Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Fukangning Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Fukangning Tablets Sales Market Share by Country (2021-2026) Table 58. Global Fukangning Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Fukangning Tablets Sales Market Share by Country (2027-2032) Table 60. Global Fukangning Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Fukangning Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Fukangning Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Fukangning Tablets Sales Value Market Share by Country (2027-2032) Table 64. Yili Pharmaceutical (Nanning) Co., Ltd. Company Information Table 65. Yili Pharmaceutical (Nanning) Co., Ltd. Business Overview Table 66. Yili Pharmaceutical (Nanning) Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Yili Pharmaceutical (Nanning) Co., Ltd. Fukangning Tablets Product Portfolio Table 68. Yili Pharmaceutical (Nanning) Co., Ltd. Recent Development Table 69. Yantai Bohai Pharmaceutical Group Co., Ltd. Company Information Table 70. Yantai Bohai Pharmaceutical Group Co., Ltd. Business Overview Table 71. Yantai Bohai Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Yantai Bohai Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio Table 73. Yantai Bohai Pharmaceutical Group Co., Ltd. Recent Development Table 74. Tonghua Baixin Pharmaceutical Co., Ltd. Company Information Table 75. Tonghua Baixin Pharmaceutical Co., Ltd. Business Overview Table 76. Tonghua Baixin Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Tonghua Baixin Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 78. Tonghua Baixin Pharmaceutical Co., Ltd. Recent Development Table 79. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Company Information Table 80. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Business Overview Table 81. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 83. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Recent Development Table 84. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Company Information Table 85. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Business Overview Table 86. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio Table 88. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Recent Development Table 89. Shaanxi Kanghui Pharmaceutical Co., Ltd. Company Information Table 90. Shaanxi Kanghui Pharmaceutical Co., Ltd. Business Overview Table 91. Shaanxi Kanghui Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Shaanxi Kanghui Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 93. Shaanxi Kanghui Pharmaceutical Co., Ltd. Recent Development Table 94. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Company Information Table 95. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Business Overview Table 96. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 98. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Recent Development Table 99. Liaoning Dongfangren Pharmaceutical Co., Ltd. Company Information Table 100. Liaoning Dongfangren Pharmaceutical Co., Ltd. Business Overview Table 101. Liaoning Dongfangren Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Liaoning Dongfangren Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 103. Liaoning Dongfangren Pharmaceutical Co., Ltd. Recent Development Table 104. Lanzhou Weici Pharmaceutical Co., Ltd. Company Information Table 105. Lanzhou Weici Pharmaceutical Co., Ltd. Business Overview Table 106. Lanzhou Weici Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Lanzhou Weici Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 108. Lanzhou Weici Pharmaceutical Co., Ltd. Recent Development Table 109. Lanzhou Foci Pharmaceutical Co., Ltd. Company Information Table 110. Lanzhou Foci Pharmaceutical Co., Ltd. Business Overview Table 111. Lanzhou Foci Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Lanzhou Foci Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 113. Lanzhou Foci Pharmaceutical Co., Ltd. Recent Development Table 114. Jinhua Kangshou Pharmaceutical Co., Ltd. Company Information Table 115. Jinhua Kangshou Pharmaceutical Co., Ltd. Business Overview Table 116. Jinhua Kangshou Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Jinhua Kangshou Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 118. Jinhua Kangshou Pharmaceutical Co., Ltd. Recent Development Table 119. Jiangsu Yihai Pharmaceutical Co., Ltd. Company Information Table 120. Jiangsu Yihai Pharmaceutical Co., Ltd. Business Overview Table 121. Jiangsu Yihai Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Jiangsu Yihai Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 123. Jiangsu Yihai Pharmaceutical Co., Ltd. Recent Development Table 124. Jilin Jurentang Pharmaceutical Co., Ltd. Company Information Table 125. Jilin Jurentang Pharmaceutical Co., Ltd. Business Overview Table 126. Jilin Jurentang Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Jilin Jurentang Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 128. Jilin Jurentang Pharmaceutical Co., Ltd. Recent Development Table 129. Huaihua Zhenghao Pharmaceutical Co., Ltd. Company Information Table 130. Huaihua Zhenghao Pharmaceutical Co., Ltd. Business Overview Table 131. Huaihua Zhenghao Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Huaihua Zhenghao Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 133. Huaihua Zhenghao Pharmaceutical Co., Ltd. Recent Development Table 134. Henan Zhongjing Pharmaceutical Co., Ltd. Company Information Table 135. Henan Zhongjing Pharmaceutical Co., Ltd. Business Overview Table 136. Henan Zhongjing Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Henan Zhongjing Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 138. Henan Zhongjing Pharmaceutical Co., Ltd. Recent Development Table 139. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Company Information Table 140. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Business Overview Table 141. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 143. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Recent Development Table 144. Guangxi Weiwe Pharmaceutical Co., Ltd. Company Information Table 145. Guangxi Weiwe Pharmaceutical Co., Ltd. Business Overview Table 146. Guangxi Weiwe Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Guangxi Weiwe Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 148. Guangxi Weiwe Pharmaceutical Co., Ltd. Recent Development Table 149. Guangxi Shuangyi Pharmaceutical Co., Ltd. Company Information Table 150. Guangxi Shuangyi Pharmaceutical Co., Ltd. Business Overview Table 151. Guangxi Shuangyi Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Guangxi Shuangyi Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 153. Guangxi Shuangyi Pharmaceutical Co., Ltd. Recent Development Table 154. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Company Information Table 155. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Business Overview Table 156. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 158. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Recent Development Table 159. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Company Information Table 160. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Business Overview Table 161. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio Table 163. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Recent Development Table 164. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Company Information Table 165. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Business Overview Table 166. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio Table 168. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Recent Development Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Fukangning Tablets Distributors List Table 172. Fukangning Tablets Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Fukangning Tablets Product Image Figure 2. Global Fukangning Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fukangning Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Fukangning Tablets Sales (2021-2032) & (K Units) Figure 5. Global Fukangning Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Fukangning Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Film-coated Tablets Image Figure 10. Sugar-coated Tablets Image Figure 11. Global Fukangning Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Fukangning Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Fukangning Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Fukangning Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Fukangning Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Fukangning Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Fukangning Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Fukangning Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Fukangning Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Fukangning Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Fukangning Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Fukangning Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Fukangning Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Fukangning Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Fukangning Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Fukangning Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Fukangning Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Fukangning Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Fukangning Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Fukangning Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Fukangning Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Fukangning Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Fukangning Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Fukangning Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Fukangning Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Fukangning Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Fukangning Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Fukangning Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Fukangning Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Fukangning Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Fukangning Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Film-coated Tablets
  • Sugar-coated Tablets
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yili Pharmaceutical (Nanning) Co., Ltd.
  • Yantai Bohai Pharmaceutical Group Co., Ltd.
  • Tonghua Baixin Pharmaceutical Co., Ltd.
  • Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd.
  • Shaanxi Panlong Pharmaceutical Group Co., Ltd.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd.
  • Sanmenxia Guangyu Biopharmaceutical Co., Ltd.
  • Liaoning Dongfangren Pharmaceutical Co., Ltd.
  • Lanzhou Weici Pharmaceutical Co., Ltd.
  • Lanzhou Foci Pharmaceutical Co., Ltd.
  • Jinhua Kangshou Pharmaceutical Co., Ltd.
  • Jiangsu Yihai Pharmaceutical Co., Ltd.
  • Jilin Jurentang Pharmaceutical Co., Ltd.
  • Huaihua Zhenghao Pharmaceutical Co., Ltd.
  • Henan Zhongjing Pharmaceutical Co., Ltd.
  • Guangzhou Xiangxue Pharmaceutical Co., Ltd.
  • Guangxi Weiwe Pharmaceutical Co., Ltd.
  • Guangxi Shuangyi Pharmaceutical Co., Ltd.
  • Guangxi Jinsuozi Pharmaceutical Co., Ltd.
  • Guangxi Fanglue Pharmaceutical Group Co., Ltd.
  • Guangxi Bangqi Pharmaceutical Group Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fukangning Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Fukangning Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Fukangning Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Fukangning Tablets Market Dynamics
  1. 2.1 Fukangning Tablets Industry Trends
  2. 2.2 Fukangning Tablets Industry Drivers
  3. 2.3 Fukangning Tablets Industry Opportunities and Challenges
  4. 2.4 Fukangning Tablets Industry Restraints
3 Fukangning Tablets Market by Company
  1. 3.1 Global Fukangning Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Fukangning Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Fukangning Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Fukangning Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Fukangning Tablets Company Ranking (2024-2026)
  6. 3.6 Global Fukangning Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Fukangning Tablets Company Product Type and Application
  8. 3.8 Global Fukangning Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Fukangning Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Fukangning Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Fukangning Tablets Market by Type
  1. 4.1 Fukangning Tablets Type Introduction
  2. 4.1.1 Film-coated Tablets
  3. 4.1.2 Sugar-coated Tablets
  4. 4.2 Global Fukangning Tablets Sales Volume by Type
  5. 4.2.1 Global Fukangning Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Fukangning Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Fukangning Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Fukangning Tablets Sales Value by Type
  9. 4.3.1 Global Fukangning Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Fukangning Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Fukangning Tablets Sales Value Share by Type (2021-2032)
5 Fukangning Tablets Market by Application
  1. 5.1 Fukangning Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Fukangning Tablets Sales Volume by Application
  6. 5.2.1 Global Fukangning Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fukangning Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Fukangning Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Fukangning Tablets Sales Value by Application
  10. 5.3.1 Global Fukangning Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Fukangning Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Fukangning Tablets Sales Value Share by Application (2021-2032)
6 Fukangning Tablets Regional Sales and Value Analysis
  1. 6.1 Global Fukangning Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fukangning Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Fukangning Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Fukangning Tablets Sales by Region (2027-2032)
  5. 6.3 Global Fukangning Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Fukangning Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Fukangning Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Fukangning Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Fukangning Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Fukangning Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Fukangning Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Fukangning Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Fukangning Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Fukangning Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Fukangning Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Fukangning Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Fukangning Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Fukangning Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Fukangning Tablets Sales Value Share by Country, 2025 VS 2032
7 Fukangning Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Fukangning Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fukangning Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Fukangning Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Fukangning Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Fukangning Tablets Sales by Country (2027-2032)
  6. 7.4 Global Fukangning Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Fukangning Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Fukangning Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Fukangning Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Fukangning Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Fukangning Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Fukangning Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Fukangning Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Fukangning Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Fukangning Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Fukangning Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Fukangning Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Fukangning Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Fukangning Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Fukangning Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Fukangning Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Fukangning Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Fukangning Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Fukangning Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Fukangning Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Fukangning Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Fukangning Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Fukangning Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Fukangning Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Fukangning Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Fukangning Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Fukangning Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Fukangning Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Fukangning Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Fukangning Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Fukangning Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Fukangning Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Fukangning Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yili Pharmaceutical (Nanning) Co., Ltd.
  2. 8.1.1 Yili Pharmaceutical (Nanning) Co., Ltd. Company Information
  3. 8.1.2 Yili Pharmaceutical (Nanning) Co., Ltd. Business Overview
  4. 8.1.3 Yili Pharmaceutical (Nanning) Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yili Pharmaceutical (Nanning) Co., Ltd. Fukangning Tablets Product Portfolio
  6. 8.1.5 Yili Pharmaceutical (Nanning) Co., Ltd. Recent Developments
  7. 8.2 Yantai Bohai Pharmaceutical Group Co., Ltd.
  8. 8.2.1 Yantai Bohai Pharmaceutical Group Co., Ltd. Company Information
  9. 8.2.2 Yantai Bohai Pharmaceutical Group Co., Ltd. Business Overview
  10. 8.2.3 Yantai Bohai Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yantai Bohai Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio
  12. 8.2.5 Yantai Bohai Pharmaceutical Group Co., Ltd. Recent Developments
  13. 8.3 Tonghua Baixin Pharmaceutical Co., Ltd.
  14. 8.3.1 Tonghua Baixin Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Tonghua Baixin Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Tonghua Baixin Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Tonghua Baixin Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  18. 8.3.5 Tonghua Baixin Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd.
  20. 8.4.1 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  24. 8.4.5 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Shaanxi Panlong Pharmaceutical Group Co., Ltd.
  26. 8.5.1 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Company Information
  27. 8.5.2 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Business Overview
  28. 8.5.3 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio
  30. 8.5.5 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Recent Developments
  31. 8.6 Shaanxi Kanghui Pharmaceutical Co., Ltd.
  32. 8.6.1 Shaanxi Kanghui Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Shaanxi Kanghui Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Shaanxi Kanghui Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shaanxi Kanghui Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  36. 8.6.5 Shaanxi Kanghui Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Sanmenxia Guangyu Biopharmaceutical Co., Ltd.
  38. 8.7.1 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  42. 8.7.5 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Liaoning Dongfangren Pharmaceutical Co., Ltd.
  44. 8.8.1 Liaoning Dongfangren Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Liaoning Dongfangren Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Liaoning Dongfangren Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Liaoning Dongfangren Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  48. 8.8.5 Liaoning Dongfangren Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Lanzhou Weici Pharmaceutical Co., Ltd.
  50. 8.9.1 Lanzhou Weici Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Lanzhou Weici Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Lanzhou Weici Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lanzhou Weici Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  54. 8.9.5 Lanzhou Weici Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Lanzhou Foci Pharmaceutical Co., Ltd.
  56. 8.10.1 Lanzhou Foci Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Lanzhou Foci Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Lanzhou Foci Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Lanzhou Foci Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  60. 8.10.5 Lanzhou Foci Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Jinhua Kangshou Pharmaceutical Co., Ltd.
  62. 8.11.1 Jinhua Kangshou Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Jinhua Kangshou Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Jinhua Kangshou Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Jinhua Kangshou Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  66. 8.11.5 Jinhua Kangshou Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Jiangsu Yihai Pharmaceutical Co., Ltd.
  68. 8.12.1 Jiangsu Yihai Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Jiangsu Yihai Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Jiangsu Yihai Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Jiangsu Yihai Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  72. 8.12.5 Jiangsu Yihai Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Jilin Jurentang Pharmaceutical Co., Ltd.
  74. 8.13.1 Jilin Jurentang Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Jilin Jurentang Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Jilin Jurentang Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Jilin Jurentang Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  78. 8.13.5 Jilin Jurentang Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Huaihua Zhenghao Pharmaceutical Co., Ltd.
  80. 8.14.1 Huaihua Zhenghao Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Huaihua Zhenghao Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Huaihua Zhenghao Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Huaihua Zhenghao Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  84. 8.14.5 Huaihua Zhenghao Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Henan Zhongjing Pharmaceutical Co., Ltd.
  86. 8.15.1 Henan Zhongjing Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Henan Zhongjing Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Henan Zhongjing Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Henan Zhongjing Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  90. 8.15.5 Henan Zhongjing Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Guangzhou Xiangxue Pharmaceutical Co., Ltd.
  92. 8.16.1 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  96. 8.16.5 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Guangxi Weiwe Pharmaceutical Co., Ltd.
  98. 8.17.1 Guangxi Weiwe Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Guangxi Weiwe Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Guangxi Weiwe Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Guangxi Weiwe Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  102. 8.17.5 Guangxi Weiwe Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Guangxi Shuangyi Pharmaceutical Co., Ltd.
  104. 8.18.1 Guangxi Shuangyi Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Guangxi Shuangyi Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Guangxi Shuangyi Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Guangxi Shuangyi Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  108. 8.18.5 Guangxi Shuangyi Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Guangxi Jinsuozi Pharmaceutical Co., Ltd.
  110. 8.19.1 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Company Information
  111. 8.19.2 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Business Overview
  112. 8.19.3 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  114. 8.19.5 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Recent Developments
  115. 8.20 Guangxi Fanglue Pharmaceutical Group Co., Ltd.
  116. 8.20.1 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Company Information
  117. 8.20.2 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Business Overview
  118. 8.20.3 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio
  120. 8.20.5 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Recent Developments
  121. 8.21 Guangxi Bangqi Pharmaceutical Group Co., Ltd.
  122. 8.21.1 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Company Information
  123. 8.21.2 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Business Overview
  124. 8.21.3 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio
  126. 8.21.5 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fukangning Tablets Value Chain Analysis
  2. 9.1.1 Fukangning Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fukangning Tablets Sales Mode & Process
  6. 9.2 Fukangning Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fukangning Tablets Distributors
  9. 9.2.3 Fukangning Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst